Clinico-angiographic profiles and in-hospital outcomes of non-ST segment elevation myocardial infarction in Kurdistan Region of Iraq

Authors

  • Ameen M Mohammad Department of Internal Medicine, College of Medicine, Duhok University, Duhok, Iraq.
  • Haval A Issa Duhok Heart Center, Azadi teaching Hospital, Duhok, Iraq.
  • Saad Y Saeed Department of Community Medicine, College of medicine, University of Duhok, Iraq.

DOI:

https://doi.org/10.22317/jcms.v8i4.1249

Keywords:

Acute Coronary Syndrome, Non-ST Elevated Myocardial Infarction, coronary intervention in NSTEMI

Abstract

Objectives: This work aimed to study the clinical, angiographic profiles and in-hospital outcomes of NSTEMI cases in Duhok, Iraq.

Methods: This prospective study involved 283 patients with NSTEMI who were admitted to Azadi teaching hospital/Azadi heart center in Duhok, Kurdistan region of Iraq, between 2021 and 2022. The patient's demographic variables, major cardiovascular risk factors (smoking, hypertension, diabetes mellitus, hyperlipidemia and family history of coronary artery disease), clinical presentation, past history of myocardial infarction/ previous percutaneous coronary intervention (PCI) and drug history were collected. The GRACE risk score was calculated for each patient. Patients were followed up regarding the management strategies (whether conservative or invasive approach), and in-hospital complications and outcomes.

Results: The mean GRACE score was 142±26. 70% of cases underwent coronary angiography/ angioplasty, with a mean time to the coronary intervention of 8 days. 17% of the sample had developed different cardiovascular complications, with heart failure being the most common. The mortality rate was 7.4%.

Conclusion: The study demonstrated higher complications and mortality rates, especially among patients with higher GRACE scores, compared to rates found in most available studies, particularly in western countries. This finding could be secondary to a suboptimal coronary intervention for NSTEMI in terms of time to intervention and the proportion of patients who underwent it.

References

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012;380(9859):2095-128.

Mohammad AM, Jehangeer HI, Shaikhow SK. Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq. BMC cardiovascular disorders. 2015;15(1):1-6.

Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1483-92.

Members WG, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):447-54.

Braunwald E, Morrow DA. Unstable angina: is it time for a requiem? Circulation. 2013;127(24):2452-7.

Mohammad AM, Othman GO, Saeed CH, Al Allawi S, Gedeon GS, Qadir SM, et al. Genetic polymorphisms in early-onset myocardial infarction in a sample of Iraqi patients: a pilot study. BMC Research Notes. 2020;13(1):1-6.

Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(18):e426-e579.

Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non–ST elevation MI: a method for prognostication and therapeutic decision making. Jama. 2000;284(7):835-42.

Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. Jama. 2004;291(22):2727-33.

Members WC, Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;79(2):e21-e129.

Gilutz H, Shindel S, Shoham-Vardi I. Adherence to NSTEMI Guidelines in the Emergency Department: Regression to Reality. Critical pathways in cardiology. 2019;18(1):40-6.

Puymirat E, Bonaca M, Fumery M, Tea V, Aissaoui N, Lemesles G, et al. Atherothrombotic risk stratification after acute myocardial infarction: the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French registry of acute ST elevation or non‐ST elevation myocardial infarction registries. Clinical cardiology. 2019;42(2):227-34.

Mohammad AM, Rashad HH, Habeeb QS, Rashad BH, Saeed SY. Demographic, clinical and angiographic profile of coronary artery disease in kurdistan region of Iraq. American Journal of Cardiovascular Disease. 2021;11(1):39.

Bønaa KH, Steigen T. Coronary angiography in non-ST-elevation acute myocardial infarction–whom and when? Tidsskrift for Den norske legeforening. 2017.

Mohammad AM, Guelker HK, Sheikhow SK. Incidence and Prognostic Significance of Myocardial Injury after Elective Percutaneous Coronary Intervention in Duhok, Iraq. J Contemp Med Sci| Vol. 2021;7(5):290-4.

Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European heart journal. 2021;42(14):1289-367.

Mohammad AM, Abdulhaleem BH, Habeeb QS. First 24 h'outcomes of acute coronary syndrome in Iraq. Medical Journal of Babylon. 2020;17(2):154.

Fox KA, Eagle KA, Gore JM, Steg PG, Anderson F, GRACE, et al. The global registry of acute coronary events, 1999 to 2009–GRACE. Heart. 2010;96(14):1095-101.

Donataccio MP, Puymirat E, Vassanelli C, Blanchard D, le Breton H, Perier M-C, et al. Presentation and revascularization patterns of patients admitted for acute coronary syndromes in France between 2004 and 2008 (from the National Observational Study of Diagnostic and Interventional Cardiac Catheterization [ONACI]). The American Journal of Cardiology. 2014;113(2):243-8.

Mohammad AM, Mohammed SU, Saeed SY. Outcomes of primary percutaneous coronary intervention in ST-Segment elevation myocardial infarction in Kurdistan Region of Iraq. Journal of Contemporary Medical Sciences. 2022;8(2).

Kinsara AJ, Ismail YM. Gender differences in patients presenting with non-ST segment elevation myocardial infarction in the STAR registry. The Egyptian Heart Journal. 2021;73(1):54.

Abdelmoneim HM, Hasan-Ali H, Abdulkader SS. Demographics of acute coronary syndrome (ACS) Egyptian patients admitted to Assiut University Hospital: Validation of TIMI and GRACE scores. The Egyptian Journal of Critical Care Medicine. 2014;2(1):3-11.

Mohammad AM, Al-Allawi NA. CYP2C19 genotype is an independent predictor of adverse cardiovascular outcome in Iraqi patients on clopidogrel after percutaneous coronary intervention. Journal of cardiovascular pharmacology. 2018;71(6):347-51.

Mrsic D, Smajlovic J, Loncar D, Avdic S, Avdagic M, Smajic E, et al. Risk factors in patients with non-ST segment elevation myocardial infarction. Materia Socio-medica. 2020;32(3):224.

Mohammad A, Othman G, Saeed C, Allawi N. TCT-441 Traditional and genetic risk factors in young patients with myocardial infarction in Iraq. Journal of the American College of Cardiology. 2017;70(18S):B181-B.

Amsterdam EA, Wenger NK, Brindis RG, Casey Jr DE, Ganiats TG, Holmes Jr DR, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354-94.

Dakhil ZA, Farhan HA. Non-ST elevation acute coronary syndromes; clinical landscape, management strategy and in-hospital outcomes: an age perspective. The Egyptian Heart Journal. 2021;73(1):1-11.

Butt JH, Kofoed KF, Kelbæk H, Hansen PR, Torp‐Pedersen C, Høfsten D, et al. Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial. Journal of the American Heart Association. 2021;10(19):e022333.

Hamid MB. Clinical Characteristics and Outcomes of Acute Coronary Syndromes in a Group of Iraqi Patients. Iraqi Journal of Medical Sciences. 2016;14(4).

Fox K, Gore J. The Global Registry of Acute Coronary Events (GRACE). Heart. 2007;93:177-82.

Yusufali AM, AlMahmeed W, Tabatabai S, Rao K, Binbrek A. Acute coronary syndrome registry from four large centres in United Arab Emirates (UAE-ACS Registry). Heart Asia. 2010;2(1):118-21.

Cortell A, Sanchis J, Bodí V, Núñez J, Mainar L, Pellicer M, et al. Non-ST-elevation acute myocardial infarction with normal coronary arteries: predictors and prognosis. Revista Española de Cardiología (English Edition). 2009;62(11):1260-6.

Mohammad AM, Sheikho SK, Tayib JM. Relation of cardiovascular risk factors with coronary angiographic findings in Iraqi patients with ischemic heart disease. Am J Cardiovasc Dis Res. 2013;1(1):25-9.

Milasinovic D, Milosevic A, Marinkovic J, Vukcevic V, Ristic A, Asanin M, et al. Timing of invasive strategy in NSTE-ACS patients and effect on clinical outcomes: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis. 2015;241(1):48-54.

Case BC, Yerasi C, Wang Y, Forrestal BJ, Hahm J, Dolman S, et al. Admissions rate and timing of revascularization in the United States in patients with non-ST-elevation myocardial infarction. The American Journal of Cardiology. 2020;134:24-31.

Martinón-Martínez J, Alvarez Alvarez B, Gonzalez Ferrero T, Garcia-Rodeja Arias F, Otero Garcia O, Cacho Antonio C, et al. Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines. Clinical Research in Cardiology. 2021;110(9):1464-72.

Hall M, Bebb OJ, Dondo TB, Yan AT, Goodman SG, Bueno H, et al. Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction. European Heart Journal. 2018;39(42):3798-806.

Cakar MA, Sahinkus S, Aydin E, Vatan MB, Keser N, Akdemir R, et al. Relation between the GRACE score and severity of atherosclerosis in acute coronary syndrome. Journal of Cardiology. 2014;63(1):24-8.

Rahmani R, Majidi B, Ariannejad H, Shafiee A. The value of the grace score for predicting the syntax score in patients with unstable angina/non-ST elevation myocardial infarction. Cardiovascular Revascularization Medicine. 2020;21(4):514-7.

Kumar D, Ashok A, Saghir T, Khan N, Solangi BA, Ahmed T, et al. Prognostic value of GRACE score for in-hospital and 6 months outcomes after non-ST elevation acute coronary syndrome. The Egyptian Heart Journal. 2021;73(1):1-5.

Published

2022-08-26

How to Cite

Mohammad, A. M. ., Issa, H. A. ., & Saeed, S. Y. . (2022). Clinico-angiographic profiles and in-hospital outcomes of non-ST segment elevation myocardial infarction in Kurdistan Region of Iraq. Journal of Contemporary Medical Sciences, 8(4). https://doi.org/10.22317/jcms.v8i4.1249